References
- Schebesch KM, Hoehne J, Hohenberger C, et al. Fluorescein sodium-guided surgery in cerebral lymphoma. Clin Neurol Neurosurg 2015;139:125–8.
- Shin DJ, Lee EJ, Lee JE, et al. Common and uncommon features of central nervous system lymphoma on traditional and advanced imaging modalities. Neurographics 2017;7:437–49.
- Bellinzona M, Roser F, Ostertag H, et al. Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a serie of 33 cases. European J Surg Oncol 2005;31:100–5.
- Weller M, Martus P, Roth P, Thiel E, Korfel A. German PCNSL Study Group. Surgery for primary CNS lymphoma: challenging a paradigm. Neuro Oncol 2012;14:1481–4.
- Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000;92:261–6.
- Capitanio JF, Camporesi S, Franzin A, et al. Inverted positioning of Leksell frame G for very low posterior fossa and brain stem lesions biopsies. J Neurosurg Sci In press, 2016.
- Acerbi F, Cavallo C, Broggi M, et al. Fluorescein-guided surgery for malignant gliomas: a review. Neurosurg Rev 2014;37:47–57.
- Acerbi F, Broggi M, Broggi G, Ferroli F. What is the best timing for fluorescein injection during surgical removal of high-grade gliomas. Acta Neurochir 2015;157:1377–8.
- Lin F, Zhang X, Zhang J, et al. Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI. J Neurooncol 2018;139:757–65.
- Okuda T, Kataoka K, Kato A. Effectiveness of intraoperative fluorescence for diagnosis of malignant lymphoma. No Shinkei Geka 2008;36:1001–4.
- Hoang-Xuan K, Bessell E, Bromberg J, et al. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol 2015;16:e322–32.
- Acerbi F, Broggi M, Eoli M, et al. Is fluorescein-guided technique able to help in resection of high-grade gliomas. Neurosurg Focus 2014;36:E5.